FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthias Riemenschneider

Research Profile

Disorders

Physiology

Chemicals & Drugs

Genes & Molecular Sequences

Geographic Areas

Germany

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Patricia Friedrich; T M Feulner; Simon Laws; K Eckart; Robert Perneczky; Alexander Kurz; hans förstl; Matthias Riemenschneider
No association of Tachykinin receptor 2 (TACR2) polymorphisms with Alzheimer's disease.
Simon Laws; K Eckart; Patricia Friedrich; Alexander Kurz; hans förstl; Matthias Riemenschneider
Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease.
Simon Laws; K Eckart; Patricia Friedrich; Tamara Eisele; Alexander Kurz; hans förstl; Matthias Riemenschneider
No association of lipase C polymorphisms with Alzheimer's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthias Riemenschneider (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Patricia Friedrich; T M Feulner; Simon Laws; K Eckart; Robert Perneczky; Alexander Kurz; hans förstl; Matthias Riemenschneider
No association of Tachykinin receptor 2 (TACR2) polymorphisms with Alzheimer's disease.
Neurobiology of aging 2011;32(3):544-5.
2011: Simon Laws; K Eckart; Patricia Friedrich; Alexander Kurz; hans förstl; Matthias Riemenschneider
Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease.
Neurobiology of aging 2011;32(3):541-3.
2010: Simon Laws; K Eckart; Patricia Friedrich; Tamara Eisele; Alexander Kurz; hans förstl; Matthias Riemenschneider
No association of lipase C polymorphisms with Alzheimer's disease.
Neurobiology of aging 2010;31(12):2192-3.
2010: T M Feulner; Simon Laws; Patricia Friedrich; Stefan Wagenpfeil; S H R Wurst; C Riehle; Klaus A Kuhn; M Krawczak; S Schreiber; S Nikolaus; hans förstl; Alexander Kurz; Matthias Riemenschneider
Examination of the current top candidate genes for AD in a genome-wide association study.
Molecular psychiatry 2010;15(7):756-66.
2009: Axel Schumacher; Patricia Friedrich; Janine Diehl; Bernd Ibach; Andreas Schoepfer-Wendels; Jakob C Mueller; Lidija Konta; Simon Laws; Alexander Kurz; hans förstl; Matthias Riemenschneider
No association of common VCP variants with sporadic frontotemporal dementia.
Neurobiology of aging 2009;30(2):333-5.
2009: Ruth Vukovich; Robert Perneczky; Alexander Drzezga; hans förstl; Alexander Kurz; Matthias Riemenschneider
Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease.
Dementia and geriatric cognitive disorders 2009;27(5):474-80.
2009: Axel Schumacher; Patricia Friedrich; Janine Diehl-Schmid; Bernd Ibach; Robert Perneczky; Tamara Eisele; Ruth Vukovich; hans förstl; Matthias Riemenschneider
No association of TDP-43 with sporadic frontotemporal dementia.
Neurobiology of aging 2009;30(1):157-9.
2008: Simon Laws; Patricia Friedrich; Janine Diehl-Schmid; J Müller; Bernd Ibach; Josef Bäuml; Tamara Eisele; hans förstl; Alexander Kurz; Matthias Riemenschneider
Genetic analysis of MAPT haplotype diversity in frontotemporal dementia.
Neurobiology of aging 2008;29(8):1276-8.
2007: Axel Schumacher; Patricia Friedrich; Janine Diehl-Schmid; Bernd Ibach; Tamara Eisele; Simon Laws; hans förstl; Alexander Kurz; Matthias Riemenschneider
No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia.
Neurobiology of aging 2007;28(11):1789-90.
2007: Simon Laws; Robert Perneczky; Alexander Drzezga; Janine Diehl-Schmid; Bernd Ibach; Josef Bäuml; Tamara Eisele; hans förstl; Alexander Kurz; Matthias Riemenschneider
Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia.
The American journal of psychiatry 2007;164(10):1577-84.
2007: Matthias Riemenschneider; A Schoepfer-Wendels; Patricia Friedrich; Lidija Konta; Simon Laws; Jakob C Mueller; Alexander Kurz; hans förstl
No association of vacuolar protein sorting 26 polymorphisms with Alzheimer's disease.
Neurobiology of aging 2007;28(6):883-4.
2007: Simon Laws; Patricia Friedrich; Janine Diehl-Schmid; J Müller; Tamara Eisele; J Bäuml; hans förstl; Alexander Kurz; Matthias Riemenschneider
Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease.
Molecular psychiatry 2007;12(5):510-7.
2007: Jakob C Mueller; Matthias Riemenschneider; Andreas Schoepfer-Wendels; Henning Gohlke; Lidija Konta; Patricia Friedrich; Thomas Illig; Simon Laws; hans förstl; Alexander Kurz
Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures.
Neurobiology of aging 2007;28(5):727-34.
2007: Janine Diehl-Schmid; Timo Grimmer; Alexander Drzezga; Susanne Bornschein; Matthias Riemenschneider; hans förstl; M Schwaiger; Alexander Kurz
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study.
Neurobiology of aging 2007;28(1):42-50.
2006: Matthias Riemenschneider; Lidija Konta; Patricia Friedrich; Sandra Schwarz; Kevin Taddei; Frauke Neff; Alessandro Padovani; Heike Kölsch; Simon Laws; Norman Klopp; Heike Bickeböller; Stefan Wagenpfeil; Jakob C Mueller; Albert Rosenberger; Janine Diehl-Schmid; Silvana Archetti; Nicola T Lautenschlager; Barbara Borroni; Ulrich Müller; Thomas Illig; Reinhard Heun; Rupert Egensperger; Jürgen Schlegel; hans förstl; Ralph N Martins; Alexander Kurz
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
Human molecular genetics 2006;15(16):2446-56.
2006: Candan Depboylu; Frank Lohmüller; Yansheng Du; Matthias Riemenschneider; Alexander Kurz; Thomas Gasser; Ulrich Müller; Richard Dodel
Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
Neuroscience letters 2006;400(3):187-90.
2006: Matthias Riemenschneider; Kaj Blennow; Stefan Wagenpfeil; Niels Andreasen; Jonathan A Prince; Simon Laws; hans förstl; Alexander Kurz
The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.
Human mutation 2006;27(6):532-7.
2006: Henning Gohlke; Thomas Illig; Norman Klopp; Stefan Wagenpfeil; Lidija Konta; Simon Laws; Alexander Kurz; Matthias Riemenschneider
Association study between the D10S1423 microsatellite marker and Alzheimer's disease.
Neurobiology of aging 2006;27(5):776.e1-776.e3.
2006: Horst Bickel; Matthias Riemenschneider; Alexander Kurz
[Associations between dementia and head circumference as a measure of brain reserve--results from the Bavarian School sisters study].
Psychiatrische Praxis 2006;33(3):138-44.
2005: Achim Berthele; Stefan Platzer; Burkard Jochim; Henning Boecker; Andreas Buettner; Bastian Conrad; Matthias Riemenschneider; Thomas R Toelle
COMT Val108/158Met genotype affects the mu-opioid receptor system in the human brain: evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression.
NeuroImage 2005;28(1):185-93.
2005: Alexander Drzezga; Timo Grimmer; Matthias Riemenschneider; Nicola T Lautenschlager; Hartwig R Siebner; Panagiotis Alexopoulus; Satoshi Minoshima; Markus Schwaiger; Alexander Kurz
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(10):1625-32.
2005: Simon Laws; Robert Perneczky; Stefan Wagenpfeil; Ulrich Müller; hans förstl; Ralph N Martins; Alexander Kurz; Matthias Riemenschneider
TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.
Human mutation 2005;26(1):29-35.
2005: Alexander Drzezga; Matthias Riemenschneider; B Strassner; Timo Grimmer; Martin Peller; A Knoll; Stefan Wagenpfeil; Satoshi Minoshima; Markus Schwaiger; Alexander Kurz
Cerebral glucose metabolism in patients with AD and different APOE genotypes.
Neurology 2005;64(1):102-7.
2004: Matthias Riemenschneider; Shokoufeh Mahmoodzadeh; Tamara Eisele; Norman Klopp; S Schwarz; Stefan Wagenpfeil; Janine Diehl; U Mueller; hans förstl; Thomas Illig; Alexander Kurz
Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease.
Neurobiology of aging 2004;25(10):1305-8.
2004: Janine Diehl; Timo Grimmer; Alexander Drzezga; Matthias Riemenschneider; hans förstl; Alexander Kurz
Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study.
Neurobiology of aging 2004;25(8):1051-6.
2004: Matthias Riemenschneider; Norman Klopp; W Xiang; Stefan Wagenpfeil; C Vollmert; U Müller; hans förstl; Thomas Illig; Hans A Kretzschmar; Alexander Kurz
Prion protein codon 129 polymorphism and risk of Alzheimer disease.
Neurology 2004;63(2):364-6.
2003: Alexander Drzezga; Nicola T Lautenschlager; Hartwig R Siebner; Matthias Riemenschneider; Frode Willoch; Satoshi Minoshima; Markus Schwaiger; Alexander Kurz
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
European journal of nuclear medicine and molecular imaging 2003;30(8):1104-13.
2003: S Schwarz; Tamara Eisele; Janine Diehl; U Müller; hans förstl; Alexander Kurz; Matthias Riemenschneider
Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease.
Neuroscience letters 2003;343(3):167-70.
2003: Candan Depboylu; Yansheng Du; Ulrich Müller; Alexander Kurz; Reinhilde Zimmer; Matthias Riemenschneider; Thomas Gasser; Wolfgang H Oertel; Thomas Klockgether; Richard Dodel; Wolfgang H Oertelf
Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease.
Neuroscience letters 2003;342(1-2):132-4.
2003: Matthias Riemenschneider; Stefan Wagenpfeil; hugo vanderstichele; M Otto; J Wiltfang; Hans A Kretzschmar; Eugeen Vanmechelen; hans förstl; Alexander Kurz
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
Molecular psychiatry 2003;8(3):343-7.
2003: Alexander Kurz; Matthias Riemenschneider; Anders Wallin
Potential biological markers for cerebrovascular disease.
International psychogeriatrics / IPA 2003;15 Suppl 1():89-97.
2002: Matthias Riemenschneider; Nicola T Lautenschlager; Stefan Wagenpfeil; Janine Diehl; Alexander Drzezga; Alexander Kurz
Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.
Archives of neurology 2002;59(11):1729-34.
2002: Matthias Riemenschneider; Stefan Wagenpfeil; Janine Diehl; Nicola T Lautenschlager; T Theml; B Heldmann; Alexander Drzezga; T Jahn; hans förstl; Alexander Kurz
Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.
Neurology 2002;58(11):1622-8.
2002: Matthias Riemenschneider; Janine Diehl; U Müller; hans förstl; Alexander Kurz
Apolipoprotein E polymorphism in German patients with frontotemporal degeneration.
Journal of neurology, neurosurgery, and psychiatry 2002;72(5):639-41.
2002: Matthias Riemenschneider; M Schmolke; Nicola T Lautenschlager; hugo vanderstichele; E Vanmechelen; WG Guder; Alexander Kurz
Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease.
Neurobiology of aging 2002;23(2):205-11.
2002: Richard Dodel; Yansheng Du; Candan Depboylu; Alexander Kurz; BJ Eastwood; Martin R Farlow; Wolfgang H Oertel; Ulrich Müller; Matthias Riemenschneider
A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD.
Neurology 2002;58(4):664.
2002: Alexander Kurz; Matthias Riemenschneider; Alexander Drzezga; Nicola T Lautenschlager
The role of biological markers in the early and differential diagnosis of Alzheimer's disease.
Journal of neural transmission. Supplementum 2002;(62):127-33.
2002: Matthias Riemenschneider; S Schwarz; Stefan Wagenpfeil; Janine Diehl; U Müller; hans förstl; Alexander Kurz
A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
Molecular psychiatry 2002;7(7):782-5.
2001: Nicola T Lautenschlager; Matthias Riemenschneider; Alexander Drzezga; Alexander Kurz
Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.
Dementia and geriatric cognitive disorders 2001;12(6):379-86.
2001: hans förstl; Horst Bickel; Nicola T Lautenschlager; Matthias Riemenschneider; Alexander Kurz
[Forgetfulness and light cognitive impairment. What can the physician still tolerate?].
MMW Fortschritte der Medizin 2001;143(23):23-7.
2000: Matthias Riemenschneider; M Schmolke; Nicola T Lautenschlager; WG Guder; hugo vanderstichele; Eugeen Vanmechelen; Alexander Kurz
Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.
Neuroscience letters 2000;284(1-2):85-8.
1999: Frank Hulstaert; Kaj Blennow; Adrian Ivanoiu; H C Schoonderwaldt; Matthias Riemenschneider; P P De Deyn; C Bancher; Patrick cras; J Wiltfang; Pankaj D Mehta; Khalid Iqbal; Hans Pottel; Eugeen Vanmechelen; hugo vanderstichele
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.
Neurology 1999;52(8):1555-62.
1999: Harald Hampel; Stefan J Teipel; Frank Padberg; Andreas Haslinger; Matthias Riemenschneider; Markus Schwarz; HU Kötter; Michael Scheloske; K Buch; Susanne Stübner; RA Dukoff; RA Lasser; Norbert Müller; Trey Sunderland; Stanley I Rapoport; Hans-Jürgen Möller
Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.
Brain research 1999;823(1-2):104-12.
1998: Alexander Kurz; Matthias Riemenschneider; K Buch; Frode Willoch; P Bartenstein; U Müller; WG Guder
Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.
Alzheimer disease and associated disorders 1998;12(4):372-7.
1996: Matthias Riemenschneider; K Buch; M Schmolke; Alexander Kurz; W G Guder
Cerebrospinal protein tau is elevated in early Alzheimer's disease.
Neuroscience letters 1996;212(3):209-11.